Economic Evaluation of FebriDx®: A Novel Rapid, Point-of-Care Test for Differentiation of Viral versus Bacterial Acute Respiratory Infection in the United States
**Background:** Acute respiratory infections (ARIs) are commonly treated with antibiotics in outpatient settings, but many infections are caused by viruses and antibiotic treatment is therefore inappropriate. FebriDx®, a rapid point-of-care test that can differentiate viral from bacterial infections...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2021-09-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://jheor.scholasticahq.com/article/27753-economic-evaluation-of-febridx-a-novel-rapid-point-of-care-test-for-differentiation-of-viral-versus-bacterial-acute-respiratory-infection-in-the-un.pdf |